Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2021-08-09 AGM Information
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Results of AGM
AGM Information
2021-08-09 English
Autolus reports Q2 2021 Financial Results
Regulatory Filings Classification · 95% confidence The document is an RNS (Regulatory News Service) announcement issued by Syncona Limited regarding the financial results of its portfolio company, Autolus Therapeutics Plc. While it contains detailed financial data for Autolus, it is technically a secondary announcement by a parent company relaying information about a subsidiary's quarterly results. According to the filing definitions and the 'Menu vs Meal' rule, this is a regulatory announcement (RNS) that includes the summary of the subsidiary's interim report, rather than being the primary interim report of the filing entity itself. Q2 2021
2021-08-05 English
Result of AGM - Replacement
AGM Information Classification · 99% confidence The document explicitly states 'Result of Annual General Meeting' and details the voting outcomes for various resolutions (Ordinary, Special, Extraordinary) presented at the AGM. It also mentions the retirement of a director following the meeting. This content directly corresponds to the definition of AGM Information (AGM-R). Although it contains voting results, the primary context is the overall outcome and proceedings of the Annual General Meeting, making AGM-R a better fit than DVA (Declaration of Voting Results & Voting Rights Announcements), which is usually just the raw results summary. The document is an official announcement of the AGM results.
2021-08-03 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it contains the 'Result of Annual General Meeting' and details the voting outcomes for all resolutions proposed at the AGM, including the receipt of financial statements, re-appointment of auditors, director elections/retirements, and remuneration policy approval. This directly corresponds to the content covered by the AGM-R (AGM Information) category. Although it mentions the retirement of a director (MANG content) and the approval of financial statements (10-K/IR content), the primary purpose and structure of the filing is the official reporting of the AGM voting results.
2021-08-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a short announcement identified by the 'RNS Number' header and the explicit mention of 'RNS' at the end. The content explicitly states the 'Total number of ordinary shares in issue' and the 'total number of voting rights' as of a specific date (30 July 2021), referencing DTR 5.6.1. This type of mandatory disclosure regarding the total voting rights denominator is a standard regulatory filing, but it does not fit perfectly into the specific categories like 10-K, ER, or DIV. Since it is a regulatory announcement provided via RNS, and it concerns share structure/voting rights which is a specific regulatory requirement, it is best classified under the general regulatory filing category (RNS) or potentially a category related to share changes (SHA). However, the primary function here is a mandatory regulatory disclosure via the RNS system, which is the designated fallback/general regulatory category. Given the options, RNS is the most appropriate general regulatory filing code for this type of mandatory disclosure that isn't a specific financial report or corporate action like a dividend or share issue announcement, although it does relate to share capital.
2021-07-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed with the RNS (Regulatory News Service) and references the FCA (Financial Conduct Authority). This form is used to report changes in significant share ownership, specifically when a shareholder crosses or reaches a notification threshold (in this case, 5.0021%). This directly corresponds to the definition of 'Major Shareholding Notification'.
2021-07-27 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.